Tamoxifen and aromatase inhibitors are widely prescribed therapies for the treatment of breast cancer. Tamoxifen is a selective estrogen receptor modulator that treats hormone-sensitive breast cancers. Research has demonstrated that tamoxifen therapy improves survival and reduces the risk of developing recurrent invasive breast cancer by up to 40%.
Aromatase inhibitors are the drug of choice for the treatment of estrogen receptor– or progesterone receptor–positive breast cancer in postmenopausal women. Research on aromatase inhibitors has demonstrated improved survival in postmenopausal women, postmenopausal women with metastasis, and premenopausal women under the age of 35 with ovarian ablation.
The benefits of these agents have been clearly shown through various clinical trials, yet adherence may be challenging for some patients due to issues of drug interactions, proper education, and adverse effects. Education to prevent and treat adverse effects is of the utmost importance to promote adherence and improve the effectiveness of these medications. Advanced practitioners are in a position to prescribe these therapies, review medication interactions, educate patients, impact patients' quality of life, improve patients' sense of control, and increase patients' partnerships with their oncology providers.
In 2018 and 2020, two articles on precautions for patients taking tamoxifen and precautions for patients taking aromatase inhibitors were published in the Journal of the Advanced Practitioner in Oncology (Heery et al., 2018, 2020). Since then, more information on drug interactions has come to light. This article contains updated patient teaching sheets to aid the advanced practitioner in providing education to patients on these medications (Tables 1 and 2). Permission to reprint and distribute these sheets is granted.
Table 1. Precautions for Patients Taking Tamoxifen.
Tamoxifen has been the most widely prescribed medication for breast cancer for over 25 years. Daily use of tamoxifen has been shown to improve survival and reduce the risk of developing recurrent invasive breast cancer by up to 40%. |
Medications to Avoid or Use With Caution Certain medications should be avoided or taken with caution while taking tamoxifen, as they may provide less protection against breast cancer:
|
Anticoagulants
|
Estrogen Products/Estradiol Derivatives
|
Other Medications
|
Alcohol
|
Surgical Considerations Before surgery, please discuss tamoxifen usage with your surgeon. Tamoxifen may need to be held for several days before and after surgery to prevent the risk of increased bleeding.
|
Supplements Some herbs, supplements, and other products can impact the effectiveness of your cancer treatment. Talk with your provider or health-care team if you are taking any of these products. The products listed below may cause problems with breast cancer or breast cancer treatment when taken in concentrated doses such as supplement form. These products are not normally harmful if found in the food that you eat as part of your regular diet.
|
Note. Generic drug names and common brand names listed only. Always tell your provider or health-care team all the medications, herbs, supplements, vitamins, and minerals that you are taking. Reprint permission granted.
© 2023 Mary Heery, John Healey, Rachel Sieber, Emily McAllister, Ellen Konspore, Lisa Phuong, and George Zahrah.
Table 2. Precautions for Patients Taking Aromatase Inhibitors.
Aromatase inhibitors are the gold standard for postmenopausal women with breast cancer. Daily use of an aromatase inhibitor has been shown to improve survival and reduce the risk of developing recurrent invasive breast cancer by up to 40%. |
Medications to Avoid or Use With Caution While Taking Anastrozole or Letrozole Certain medications should be avoided or used with caution while taking anastrozole or letrozole.
|
Medications to Avoid or Use With Caution While Taking Exemestane Certain medications should be avoided or used with caution while taking exemestane.
|
Other Precautions
|
Supplements Some herbs, supplements, and other products can impact the effectiveness of your cancer treatment. Talk with your provider or health-care team if you are taking any of these products. The products listed below may cause problems with breast cancer or breast cancer treatment when taken in concentrated doses such as supplement form. These products are not normally harmful if they are found in the food that you eat as part of your regular diet.
|
Note. Generic drug names and common brand names listed only. Always tell your provider or health-care team all the medications, herbs, supplements, vitamins, minerals that you are taking. Please consult your health-care provider for more information. Reprint permission granted.
© 2023 Mary Heery, John Healey, Rachel Sieber, Emily McAllister, Ellen Konspore, Lisa Phuong, and George Zahrah.
References
- Heery, M., Corbett, P., & Zelkowitz, R. (2018). Precautions for patients taking tamoxifen. Journal of the Advanced Practitioner in Oncology, 9(1), 78–83. 10.6004/jadpro.2018.9.1.6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heery, M., Farley, S., Sparkman, R., Healy, J., Eighmy, W., Zahrah, G., & Zelkowitz, R. (2020). Precautions for patients taking aromatase inhibitors. Journal of the Advanced Practitioner in Oncology, 11(2), 184–189. 10.6004/jadpro.2020.11.2.6 [DOI] [PMC free article] [PubMed] [Google Scholar]